Reuters logo
BRIEF-Amgen pleads guilty to misbranding drugs - federal court hearing
December 18, 2012 / 3:30 PM / in 5 years

BRIEF-Amgen pleads guilty to misbranding drugs - federal court hearing

Dec 18 (Reuters) - Amgen Inc : * Pleads guilty to misbranding drugs - federal court hearing in Brooklyn, New York * Agrees to pay $612 million for civil settlement, $14 million forfeiture, $136

million criminal fine * Misbranding charge involves marketing of anemia drug aranesp

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below